source
- FDA opens applications for pilot program to speed up first-in-human testingThe U.S. Food and Drug Administration announced that it is now accepting applications for a pilot program designed to shorten the time required for drug developers to begin first‑in‑human clinical…
- 'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrandNovo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn’t one to make changes for the sake of change.